Literature DB >> 19729061

Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain.

Marco Sifringer1, Daniela Brait, Ulrike Weichelt, Gabriel Zimmerman, Stefanie Endesfelder, Felix Brehmer, Clarissa von Haefen, Alon Friedman, Hermona Soreq, Ivo Bendix, Bettina Gerstner, Ursula Felderhoff-Mueser.   

Abstract

Oxygen toxicity contributes to the pathogenesis of adverse neurological outcome in survivors of preterm birth in clinical studies. In infant rodent brains, hyperoxia triggers widespread apoptotic neurodegeneration, induces pro-inflammatory cytokines and inhibits growth factor signaling cascades. Since a tissue-protective effect has been observed for recombinant erythropoietin (rEpo), we hypothesized that rEpo would influence hyperoxia-induced oxidative stress in the developing rat brain. The aim of this study was to investigate the level of glutathione (reduced and oxidized), lipid peroxidation and the expression of heme oxygenase-1 (HO-1) and acetylcholinesterase (AChE) after hyperoxia and rEpo treatment. Six-day-old Wistar rats were exposed to 80% oxygen for 2-48 h and received 20,000 IU/kg rEpo intraperitoneally (i.p.). Sex-matched littermates kept under room air and injected with normal saline or rEpo served as controls. Treatment with rEpo significantly reduced hyperoxia-induced upregulation of oxidized glutathione (GSSG) and malondialdehyde, a product of lipid breakdown, whereas reduced glutathione (GSH) was upregulated by rEpo. In parallel, hyperoxia-treated immature rat brains revealed rEpo-suppressible upregulation of synaptic AChE-S as well as of the stress-inducible AChE-R variant, together predicting rEpo-protected cholinergic signaling and restrained inflammatory reactions. Furthermore, treatment with rEpo induced upregulation of HO-1 on mRNA, protein and activity level in the developing rat brain. Our results suggest that rEpo generates its protective effect against oxygen toxicity by a reduction of diverse oxidative stress parameters and by limiting the stressor-inducible changes in both HO-1 and cholinergic functions. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729061     DOI: 10.1016/j.bbi.2009.08.010

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  18 in total

1.  Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse.

Authors:  Qing-Hui Zhou; Eric Ka-Wai Hui; Jeff Zhiqiang Lu; Ruben J Boado; William M Pardridge
Journal:  Brain Res       Date:  2011-01-26       Impact factor: 3.252

2.  Disrupting the blood-brain barrier with focused ultrasound: Perspectives on inflammation and regeneration.

Authors:  Joseph Silburt; Nir Lipsman; Isabelle Aubert
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-10       Impact factor: 11.205

3.  Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury.

Authors:  Xiyong Fan; Annemieke Kavelaars; Cobi J Heijnen; Floris Groenendaal; Frank van Bel
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

4.  Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury.

Authors:  Lauren L Jantzie; Robert H Miller; Shenandoah Robinson
Journal:  Pediatr Res       Date:  2013-09-03       Impact factor: 3.756

Review 5.  Erythropoietin: powerful protection of ischemic and post-ischemic brain.

Authors:  Anh Q Nguyen; Brandon H Cherry; Gary F Scott; Myoung-Gwi Ryou; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-04

Review 6.  Adverse neuropsychiatric development following perinatal brain injury: from a preclinical perspective.

Authors:  Ivo Bendix; Martin Hadamitzky; Josephine Herz; Ursula Felderhoff-Müser
Journal:  Pediatr Res       Date:  2018-10-26       Impact factor: 3.756

7.  Intranasal levosimendan prevents cognitive dysfunction and apoptotic response induced by repeated isoflurane exposure in newborn rats.

Authors:  Serdar Demirgan; Onat Akyol; Zeynep Temel; Aslıhan Şengelen; Murat Pekmez; Ozancan Ulaş; Mehmet Salih Sevdi; Kerem Erkalp; Ayşin Selcan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-27       Impact factor: 3.000

8.  Activating mitochondrial function and haemoglobin expression with EH-201, an inducer of erythropoietin in neuronal cells, reverses memory impairment.

Authors:  Lin-Yea Horng; Pei-Lun Hsu; Li-Wen Chen; Wang-Zou Tseng; Kai-Tin Hsu; Chia-Ling Wu; Rong-Tsun Wu
Journal:  Br J Pharmacol       Date:  2015-08-10       Impact factor: 8.739

9.  Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage.

Authors:  Felix Brehmer; Ivo Bendix; Sebastian Prager; Yohan van de Looij; Barbara S Reinboth; Julia Zimmermanns; Gerald W Schlager; Daniela Brait; Marco Sifringer; Stefanie Endesfelder; Stéphane Sizonenko; Carina Mallard; Christoph Bührer; Ursula Felderhoff-Mueser; Bettina Gerstner
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  Erythropoietin modulates autophagy signaling in the developing rat brain in an in vivo model of oxygen-toxicity.

Authors:  Ivo Bendix; Corina Schulze; Clarissa von Haefen; Alexandra Gellhaus; Stefanie Endesfelder; Rolf Heumann; Ursula Felderhoff-Mueser; Marco Sifringer
Journal:  Int J Mol Sci       Date:  2012-10-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.